 

 

FINAL DIAGNOSIS:

PART 1: LYMPH NODE, RIGHT SENTINEL #1. EXCISION - ' ' ' ‘

 

ONE (1) LYMPH NODE, NEGATIVE FOR METASTATIC ADENOCARCINOMA (0/1). ~ "

PART 2: LYMPH NODE. RIGHT SENTINEL #2. EXCISION —

I
A. ONE (1) LYMPH NODE, POSITIVE FOR MICROMETASTASIS TWO (2) FOCI MEASURING LESS THAN 1.0 MM,

AND ONE (1) ALSO LESS THA 1.0 MM (“1) (see comment).
B. NO EXTRACAPSULAR SPREAD IS SEEN. /OA ’ 0 , 3

. ‘ ‘ 0W N05 850:)
ONE (1) LYMPH NODE, NEGATIVE FOR METASTATIC ADENOCARCINOMA (OHI- W, WI” I" ““7 ’ /3

PART 3: LYMPH NODE. RIGHT SENTINEL #3, EXCISION —

PART 4: LYMPH NODE. RIGHT NONsENTINEL, EXCISION— (57%;: W Ms 050.9 3/’3/// A/
I

ONE (1) LYMPH NODE, NEGATIVE FOR METASTATIC ADENOCARCINOMA (0“).

PART 5: B T, SEGMENTAL MASTECTOMY -

A. INFILTRATIN NOS

‘ GRADE 1, SCORE OF 5/9 (TUBULES I 2, NUCLEI = 2, MITOSIS I 1).

TUMOR MEASURES 2.0 CM ON GROSS EXAMINATION.

DUCTAL CARCINOMA IN-SITU, CRIBRIFORM TYPE AND WITH COMEDO NECROSIS, NUCLEAR GRADE 2.

ADMIXED WITH INVASIVE COMPONENT, COMPRISING APPROXIMATELY LESS THAN 5% OF THE TOTAL
TUMOR VOLUME.

SURGICAL MARGINS OF RESECTION ARE FREE OF INVASIVE TUMOR.
CLOSEST POSTERIOR AND SUPERIOR MARGINS OF RESECTION ARE AT 0.6 CM.

MARGINS OF RESECTION ARE FREE OF DUCTAL CARCINOMA IN-SITU, CLOSEST POSTERIOR MARGIN
AT 1.2 CM.

ANGIOLYMPHATIC INVASION IS IDENTIFIED.

ESTROGEN RECEPTOR POSITIVE, PROGESTERONE RECEPTOR POSITIVE, HER-ZINEU NEGATIVE
(SCORE 0), PER PREVIOUS REPORT

PP!”

T; own

SKIN WITH NO SIGNIFICANT PATHOLUGIC ABNORMALITY.

J.
K. NON-NEOPLASTIC BREAST WITH FIBROCYSTIC CHANGES, DUCTAL EPITHELIAL HYPERPLASIA, AND
FIBROADENOMATOID NODULES.

PART 6: BREAST, RIGHT MEDIAL NEW MARGIN, EXCISION —

 

BREAST TISSUE. NEGATIVE FOR TUMOR.
PART 7: BREAST. RIGHT INF

 

ERIOR NEW MARGIN, EXCISION —
A. FIBROADIPOSE TISSUE NEGATIVE FOR TUMOR.

3. F NTS OF SKELETAL MUSCLE.
C YN P IS:
AiEYSOPTec -SPRIMARY INVASIVE CARCINOMA OF BREAST
LATERALITY: Right
PROCEDURE: Segmental
LOCATION: Not speciﬁed _ . .
SIZE OF TUMOR: MaXImum dImensIon InvasIve component: 2.0 cm
MULTICENTRICITYIMULHFOCALITY O‘F INVASIVE FOCI:
o
TUMOR TYPE (Invasive component): 0 ct I d ' NOS .-- , _ > ‘ ._. _
u a a enocarcinoma, _ _ _ 75°19
NOTTINGHAM SCORE: Nuclear grade: 2 UUID :;ggg_4§g-_s;ggT{cg1lAﬁgzg ”95‘7“ Red 3 ct ed
Tubule formation: 2 I I Ill“ I“
WWWWWW III II IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII I
m 5 IIII II II IIIIII I IIIIIIIIII II I I II IIIIII I III I IIIII II III
Nottingham grade (1, 2, 3): 1 III IIIIIII II
A"°'°””"””'°'”"‘s'°"‘ “’5 |||||||||||l||ii|i|||||i|i||||||iii|||||||||||i|i||i||||||||||||
DERMAL LYMPHATIC INVASION: No
CALCIFICATION: No
TUMOR TYPE. IN SITU: Cribriform

DCIS admixed with invasive carcinoma

Percent of tumor occupied by in situ component: 5 %
SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT:

No

Distance of invasive tumor to closest margin: 6 mm
SURG MARGINS INVOLVED BY IN SITU COMPONENT:

No
Distance of in situ disease to closest margin: 12 mm
LYMPH NODES POSITIVE: 1
LYMPH NODES EXAMINED: 4
METH PH NODE EXAMINATION:
HIE stain ‘—
SENTINEL NODE METASTASIS: Yes

ONLY KERATIN POSITIVE CELLS ARE PRESENT:

No
SIZE OF NODAL METASTASES: Diameter of Iarg
LYMPH NODE METASTASIS(-ES) WITH EXTRACAPS

No
SKIN INVOLVED (ULCERATION): No
NON—NEOPLASTIC BREAST TISSUE: FCD

est lymph node metastasis: 1 mm
ULAR EXTENSION:

 
  
 
  
    

TSTAGE. PATHOLOGIC: pT1c
a :TAGE. PATHOLOGIC: pN1mi mm '

TAGE, PATHOLOGIC: pr “I °W
ESTROGEN RECEPTORS: positive yﬁﬁmmr 1 ’
PROGESTERONE RECEPTORS: positive

    

HERZINEU: zero or 1+

